Variant report
Variant | nsv10660 |
---|---|
Chromosome Location | chr5:5088517-5095759 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs576988381 | chr5:5088544-5088545 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs544538798 | chr5:5088561-5088562 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs186461210 | chr5:5088618-5088619 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs2652057 | chr5:5088630-5088631 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs569812452 | chr5:5088631-5088632 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs191702586 | chr5:5088727-5088728 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs183478774 | chr5:5088728-5088729 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs202125818 | chr5:5088825-5088826 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs200461187 | chr5:5088827-5088828 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs36022876 | chr5:5088830-5088831 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs74970264 | chr5:5088837-5088838 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs2652055 | chr5:5088859-5088860 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs182274347 | chr5:5088861-5088862 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs543493256 | chr5:5088869-5088870 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs563755825 | chr5:5088875-5088876 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs574850683 | chr5:5088876-5088877 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs537333514 | chr5:5088898-5088899 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs370655860 | chr5:5088931-5088932 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs186893134 | chr5:5088949-5088950 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs115628956 | chr5:5089038-5089039 | Enhancers Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
21 | rs559951246 | chr5:5089073-5089074 | Enhancers Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
22 | rs1382898 | chr5:5089088-5089089 | Enhancers Bivalent/Poised TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs191501930 | chr5:5089090-5089091 | Enhancers Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
24 | rs1382897 | chr5:5089096-5089097 | Enhancers Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
25 | rs529843262 | chr5:5089097-5089098 | Enhancers Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
26 | rs549820258 | chr5:5089101-5089102 | Enhancers Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
27 | rs569768895 | chr5:5089120-5089121 | Enhancers Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
28 | rs73049827 | chr5:5089123-5089124 | Enhancers Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
29 | rs577464583 | chr5:5089130-5089131 | Enhancers Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
30 | rs147567501 | chr5:5089157-5089158 | Enhancers Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
31 | rs142233657 | chr5:5089159-5089160 | Enhancers Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
32 | rs1382896 | chr5:5089229-5089230 | Bivalent/Poised TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs368430139 | chr5:5089285-5089286 | Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
34 | rs146174323 | chr5:5089339-5089340 | Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
35 | rs568089783 | chr5:5089368-5089369 | Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
36 | rs537167979 | chr5:5089374-5089375 | Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
37 | rs557388805 | chr5:5089423-5089424 | Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
38 | rs184021181 | chr5:5089434-5089435 | Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
39 | rs189600574 | chr5:5089437-5089438 | Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
40 | rs553467211 | chr5:5089455-5089456 | Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
41 | rs546426589 | chr5:5089484-5089485 | Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
42 | rs377216104 | chr5:5089497-5089498 | Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
43 | rs369719275 | chr5:5089500-5089501 | Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
44 | rs112496884 | chr5:5089501-5089502 | Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
45 | rs147636913 | chr5:5089508-5089509 | Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
46 | rs56291036 | chr5:5089525-5089526 | Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
47 | rs553285133 | chr5:5089549-5089550 | Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
48 | rs372069086 | chr5:5089566-5089567 | Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
49 | rs16874686 | chr5:5089567-5089568 | Bivalent/Poised TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs574968938 | chr5:5089598-5089599 | Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Glioblastoma multiforme | 22286061 | CNVD |
Lung cancer | 21911935 | CNVD |
Cri-du chat syndrome | 21549014 | CNVD |
Cervical squamous cell carcinoma | 21590768 | CNVD |
Melanoma | 18172304 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
renal disease | 17924346 | CNVD |
abnormal development | 18461090 | CNVD |
Lung cancer | 19547694 | CNVD |
Cri-du chat syndrome | 22283845 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Cancer | 21183584 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Cancer | 16751803 | CNVD |
Breast cancer | 17133270 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Liposarcoma | 21253554 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Cervical cancer | 21062161 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cervical cancer | 18559093 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Developmental delay | 21147756 | CNVD |
prenatal diagnosis | 22389664 | CNVD |
Bladder cancer | 21909424 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Breast cancer | 21858162 | CNVD |
Prostate cancer | 18632612 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Melanoma | 22183965 | CNVD |
Breast cancer | 21364760 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Autism | 22495311 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Schizophrenia | 23813976 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 16608533 | CNVD |
Anaplastic large cell lymphoma | 18179710 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:5088200-5089200 | Enhancers | HepG2 | liver |
2 | chr5:5089000-5089600 | Bivalent/Poised TSS | HSMMtube | muscle |
3 | chr5:5089600-5090800 | Active TSS | HSMMtube | muscle |